Drug Type Small molecule drug |
Synonyms Alvaiz |
Target |
Mechanism TPO receptor agonists(Thrombopoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (29 Nov 2023), |
Regulation- |
Molecular FormulaC30H35N5O5 |
InChIKeyXSHFVAAXJHNDKZ-OUFJFOJPSA-M |
CAS Registry2336813-25-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anemia, Aplastic | US | 29 Nov 2023 | |
Thrombocytopenia | US | 29 Nov 2023 |